Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 2Phase 2/3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia 3Myelodysplastic Syndromes 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Anemia, Refractory, with Excess of Blasts 2Warts 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Seminoma 1Recurrence 1Neutropenia 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Biphenotypic, Acute 1Infections 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1Febrile Neutropenia 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1Breast Neoplasms 1Anemia, Refractory 1Agammaglobulinemia 1

Interventions

Cyclophosphamide 2fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Radiotherapy 1Methylprednisolone 1Methotrexate 1Melphalan 1Filgrastim 1Etoposide 1Cytarabine 1Cyclosporine 1Carboplatin 1Busulfan 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Anemia, Refractory × Filgrastim × Clear all
NCT00003187 2010-02-24

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

Virginia Commonwealth University

Phase 2/3 Completed
19 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡